Discover trends, market shifts, and competitive outlooks for the oligonucleotide synthesis industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the Oligonucleotide Synthesis Market Size From 2025 to 2034?

In recent times, the market size for oligonucleotide synthesis has observed quick expansion. The market, which was valued at $10.33 billion in 2024, is predicted to surge to $11.94 billion in 2025, experiencing a compound annual growth rate (CAGR) of 15.6%. The upward growth trend in the past years can be credited to the progress in biomedical research, therapeutic development, biotechnological breakthroughs, genomic research, and the rise in DNA technologies.

In the forthcoming years, a swift expansion is anticipated in the oligonucleotide synthesis market size, with projections putting it at $22.29 billion in 2029, reflecting a compound annual growth rate (CAGR) of 16.9%. The growth trajectory during the forecast period is anticipated to be driven by advancements in diagnostic tools, RNA interference (RNAi) therapies, regenerative medicine, applications of nanotechnology, and progress in gene editing. The projected period also expects to see significant trends such as targeted drug development, innovative delivery systems, automation in synthesis, the use of CRISPR-cas technology, and the rise of next-generation sequencing (NGS).

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12176&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theOligonucleotide Synthesis Market?

The growth of the oligonucleotide synthesis market is projected to be fueled by the increasing incidence of chronic diseases. Chronic diseases are defined as conditions that persist for at least a year, necessitating consistent medical care, and may progressively worsen over time. Oligonucleotides function to regulate gene expression involved in chronic diseases through several mechanisms. These can target mRNA, pre-mRNA, or non-coding RNA to manipulate splicing events, instigate degradation, or interfere with protein translation. For example, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported in September 2022 that there were 41 million deaths worldwide, accounting for 74% of all deaths due to non-communicable diseases (NCDs) or chronic diseases annually. The report detailed 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the elevation in the occurrence of chronic and rare diseases is stimulating the expansion of the oligonucleotide synthesis market.

Which Segments in the Oligonucleotide Synthesis Offer the Most Growth?

The oligonucleotide synthesis market covered in this report is segmented –

1) By Type: Custom Oligos, Predesigned Oligos

2) By Product Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification

3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications

Subsegments:

1) By Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides

2) By Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, Primers For PCR And RT-PCR

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12176&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theOligonucleotide Synthesis Market?# Market?

North America was the largest region in the oligonucleotide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Oligonucleotide Synthesis Industry?

Product innovation has emerged as a pivotal trend in the oligonucleotide synthesis market, with major players focussing on the development of novel products to consolidate their market presence. For example, Ansa Biotechnologies, Inc., a company based in the US specializing in the manufacture of complex DNA, rolled out Ansa Clonal DNA and Ansa DNA Fragments in July 2024. Ansa Clonal DNA facilitates clonal, flawless sequences of DNA up to 600 base pairs long, negating the need for assembly, and hence delivers unmatched precision for intricate synthetic biology projects. This product guarantees error-free and ready-to-use DNA sequences, positioning it as a trustworthy choice for scientific researchers. Ansa DNA Fragments provides sequence-verified linear double-stranded DNA fragments, which can also be up to 600 base pairs long, customized for a wide array of research uses. Ansa’s innovative enzymatic synthesis method consistently generates complex DNA structures, inclusive of repeats and secondary structures, with high adaptability.

View the full report here:

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

What Are the Key Elements That Define the Oligonucleotide Synthesis Market?

Oligonucleotide synthesis is the chemical linking of nucleotides, precisely forming the desired sequenced product. This process is helpful in modern laboratory practice as it offers quick and affordable access to oligonucleotides manufactured to order with the necessary sequence.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12176

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model